Chen ZS et al. |
Early steroid withdrawal after liver transplantation for hepatocellular carcinoma. |
2007 |
World J. Gastroenterol. |
pmid:17876900
|
Li DW et al. |
Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis. |
2015 |
World J. Gastroenterol. |
pmid:26034369
|
Hilgard P et al. |
Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis. |
2006 |
World J. Gastroenterol. |
pmid:16521181
|
Jiang JW et al. |
Optimal immunosuppressor induces stable gut microbiota after liver transplantation. |
2018 |
World J. Gastroenterol. |
pmid:30228781
|
Larsen FS et al. |
Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis. |
2007 |
World J. Gastroenterol. |
pmid:17589903
|
Wietzke-Braun P et al. |
Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis C virus related cirrhosis. |
2004 |
World J. Gastroenterol. |
pmid:15259068
|
Shen T et al. |
Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation. |
2015 |
World J. Gastroenterol. |
pmid:26034381
|
Kiyama T et al. |
Tacrolimus enhances colon anastomotic healing in rats. |
2002 Sep-Oct |
Wound Repair Regen |
pmid:12406167
|
Gupta AS et al. |
Pyoderma Gangrenosum of the Scalp: A Rare Clinical Variant. |
2018 |
Wounds |
pmid:29481333
|
Zhou YN et al. |
Effect of amlodipine on the pharmacokinetics of tacrolimus in rats. |
2013 |
Xenobiotica |
pmid:23312000
|
Picard N |
The pharmacokinetic interaction between mycophenolic acid and cyclosporine revisited: a commentary on "Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus". |
2013 |
Xenobiotica |
pmid:23339626
|
Fujiyama N et al. |
Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. |
2009 |
Xenobiotica |
pmid:19274604
|
Tata PN et al. |
Species-dependent hepatic metabolism of immunosuppressive agent tacrolimus (FK-506). |
2009 |
Xenobiotica |
pmid:19604035
|
Zhang S et al. |
Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes. |
2012 |
Xenobiotica |
pmid:22106961
|
Ogawa K et al. |
A new approach to predicting human hepatic clearance of CYP3A4 substrates using monkey pharmacokinetic data. |
2013 |
Xenobiotica |
pmid:23153054
|
Lu XF et al. |
Use of a semi-physiological pharmacokinetic model to investigate the influence of itraconazole on tacrolimus absorption, distribution and metabolism in mice. |
2017 |
Xenobiotica |
pmid:27533047
|
Zhu L et al. |
Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients. |
2015 |
Xenobiotica |
pmid:25869250
|
Jeong H and Chiou WL |
Role of P-glycoprotein in the hepatic metabolism of tacrolimus. |
2006 |
Xenobiotica |
pmid:16507509
|
Chitnis SD et al. |
Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. |
2013 |
Xenobiotica |
pmid:23278282
|
Miura M et al. |
Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers. |
2005 |
Xenobiotica |
pmid:16012079
|